Telix Pharmaceuticals Limited (TLX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Telix Pharmaceuticals Lim...

NASDAQ: TLX · Real-Time Price · USD
10.28
0.06 (0.59%)
At close: Oct 03, 2025, 3:59 PM
10.33
0.49%
Pre-market: Oct 06, 2025, 04:28 AM EDT

Telix Pharmaceuticals Balance Sheet Statement

Financials in AUD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
710.35M 123.24M 116.33M 22.04M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
6.09M 12.26M -5.52M n/a
Other Long-Term Assets
74.58M 586K 327K -3.88M
Receivables
158.99M 79.53M 31.14M 20.84M
Inventory
38.14M 17.31M 5.77M 3.45M
Other Current Assets
n/a -7.66M 55.48M n/a
Total Current Assets
918.56M 224.85M 173.23M 47.54M
Property-Plant & Equipment
54.32M 30.49M 18.84M 6.33M
Goodwill & Intangibles
416.13M 109.66M 64.5M 59.83M
Total Long-Term Assets
597.87M 173.45M 87.36M 62.27M
Total Assets
1.52B 398.3M 260.59M 109.81M
Account Payables
68.7M 32.84M 16.81M 11.88M
Deferred Revenue
11.25M 10.99M 4.94M 6.14M
Short-Term Debt
18.99M 964K n/a 19K
Other Current Liabilities
109.67M 85.7M 47.33M 14.12M
Total Current Liabilities
330.91M 157.41M 85.56M 37.98M
Long-Term Debt
551.82M 8.21M 3.31M n/a
Other Long-Term Liabilities
44.67M 60.02M 55.31M 43.23M
Total Long-Term Liabilities
617.31M 91.98M 92.88M 68.19M
Total Liabilities
948.22M 249.39M 175.35M 106.17M
Total Debt
581.45M 17.45M 10.45M 2.54M
Book Value
568.21M 148.91M 85.25M 3.64M
Book Value Per Share
1.72 0.47 0.27 0.01
Common Stock
596.78M 446.27M 370.97M 170.84M
Retained Earnings
-212.96M -263.67M -272.81M -173.47M
Comprehensive Income
184.4M -33.69M -18.15M 4.79M
Shareholders Equity
568.21M 148.91M 80.01M 2.16M
Total Investments
6.09M 12.26M -5.52M n/a